What is Bain Capital Life Sciences?

Bain Capital Life Sciences is a Venture Capital based in Boston.

How many investments has Bain Capital Life Sciences made?

Bain Capital Life Sciences has made 54 disclosed investments.

How much does Bain Capital Life Sciences manage?

Bain Capital Life Sciences manages $7.4B in assets.

What does Bain Capital Life Sciences invest in?

Bain Capital Life Sciences invests in Biotech, Diagnostics, Healthcare, Medical Devices Early Stage, Growth companies.

What companies has Bain Capital Life Sciences invested in?

Bain Capital Life Sciences's portfolio includes Abcuro, Dianthus, Amunix Pharmaceuticals, HeartFlow, Cidara, Savara.

Bain Capital Life Sciences

Venture Capital

Part of Bain Capital

Bain Capital Life Sciences was founded in 2016 and invests in biopharmaceutical, medical device, diagnostic, and life science tool companies across the globe, with a focus on companies that drive medical innovation to improve the lives of patients with unmet medical needs.

Boston, United States · 54+ investments · 85 portfolio companies

Website

Early Stage

Growth

Biotech

Diagnostics

Healthcare

Medical Devices

Headquarters: Boston, United States
Founded: 2016
Website: baincapitallifesciences.com
AUM: $7.4B

Portfolio Companies: 85
Total Investments: 54
Last Investment: Feb 2026
Geographic Focus: Global

Investment Thesis

We seek to build a diverse portfolio of high-impact, high-value-creating companies by adhering to our guiding principles in our rigorous, science-first diligence. The team provides value-added strategic support to clinical and commercial-stage companies.

Bain Capital Life Sciences is a Venture Capital firm based in Boston, United States. It has made 54 investments in Biotech and Diagnostics, including Abcuro, Dianthus and Amunix Pharmaceuticals.